Company Overview
Q1: What is O-Force LLC?
A1: O-Force LLC comprises two divisions: the Catalytide Research Institute and the Minamikaze Pharmacy.
Q2: Where is the research institute of O-Force LLC located?
A2: The research institute is located within the Department of Pharmacology at Kochi University School of Medicine, utilizing its advanced research environment.
Q3: Who is the representative of O-Force LLC?
A3: The representative member is Dr. Toshifumi Akizawa, a specially appointed professor at Kochi University School of Medicine.
Q4: Who is the director of the Catalytide Research Institute?
A4: The director is Dr. Rina Nakamura, a specially appointed lecturer at Kochi University School of Medicine.
About Catalytide
Q5: What is Catalytide?
A5: Catalytide refers to a group of short synthetic peptides with enzymatic activity. It has been confirmed to break down amyloid beta proteins.
Q6: What diseases can Catalytide potentially treat?
A6: Catalytide holds promise as a treatment for neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. It is also being studied for its potential in treating amyotrophic lateral sclerosis (ALS) and IgA nephropathy.
Q7: How does Catalytide work?
A7: Catalytide breaks down and inhibits the aggregation of amyloid beta and alpha-synuclein, helping to slow disease progression and improve symptoms.
Q8: What is the method of administration for Catalytide?
A8: Catalytide has been confirmed to be effective through intranasal administration, which may reduce the burden on patients.
Research Structure and Collaborative Research
Q9: How is research and development on Catalytide organized?
A9: Research is conducted at our institute within the Department of Pharmacology at Kochi University School of Medicine. University faculty, researchers, and technical experts collaborate across various specialties.
Q10: With whom does O-Force LLC collaborate for research?
A10: We collaborate with Kochi University, aiming to initiate clinical trials.
Q11: How can companies collaborate with O-Force LLC for clinical development?
A11: Please contact us through the inquiry form or reach out to Dr. Rina Nakamura as listed in our recruitment information. We will discuss details through online meetings such as Zoom, establish a confidentiality agreement if necessary, and proceed with joint research.
To companies: We are actively seeking partnerships to bring Catalytide to the forefront of innovative therapeutic markets. We welcome your inquiries.
Intellectual Property and Academic Activities
Q12: What patents does O-Force LLC hold for Catalytide?
A12: We have obtained patents in Japan, the U.S., Europe, and China related to the hydrolytic activity of Catalytide and its ability to inhibit amyloid beta aggregation.
Q13: How does O-Force LLC contribute to academic activities?
A13: We actively present research findings at academic conferences and contribute by editing special issues in academic journals.
Social Contribution and Recruitment
Q14: How does O-Force LLC contribute to society?
A14: We host lectures for patients with Alzheimer’s and Parkinson’s diseases as well as for the general public. Additionally, we fund our research through T-shirt sales.
To the public: Our lectures provide accessible information about the latest medical advancements and prevention strategies. Please feel free to request a lecture.
Q15: What type of personnel does O-Force LLC seek?
A15: We are looking for motivated individuals to pursue a doctoral degree while contributing to the development of treatments using Catalytide. We value curiosity and physical stamina over prior knowledge or skills.
To students: Join us in cutting-edge research through graduate studies and make a significant impact on society. We look forward to your enthusiasm and dedication.
Contact Information
Q16: How can I contact O-Force LLC?
A16: Please reach out through our inquiry form or contact Dr. Rina Nakamura as listed in our recruitment information.